Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Kazuto Tajiri*, Kenichiro Tsukada, Yoshiharu Tokimitsu, Yuchi Motofuji, Kengo Kawai, Nozomu Muraishi, Aiko Murayama, Yuka Hayashi, Yukihiro Shimizu, Ichiro Yasuda

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Agricultural and Biological Sciences